2002
DOI: 10.1016/s1055-3207(03)00074-7
|View full text |Cite
|
Sign up to set email alerts
|

Randomized Clinical Trials in Melanoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2006
2006
2009
2009

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 32 publications
0
1
0
Order By: Relevance
“…Elective lymph node dissection with its associated high morbidity rates can now be avoided in patients with malignant melanoma without clinically detectable regional metastases, as it has been shown not to be associated with a survival benefit in a number of RCT 34 . The results of more than 70 RCT have also helped define the role of chemotherapy, immunotherapy and vaccine therapy in the management of the disease 35 …”
Section: Introductionmentioning
confidence: 99%
“…Elective lymph node dissection with its associated high morbidity rates can now be avoided in patients with malignant melanoma without clinically detectable regional metastases, as it has been shown not to be associated with a survival benefit in a number of RCT 34 . The results of more than 70 RCT have also helped define the role of chemotherapy, immunotherapy and vaccine therapy in the management of the disease 35 …”
Section: Introductionmentioning
confidence: 99%